γAla82Gly represents a common fibrinogen γ-chain variant in Caucasians

Blood Coagulation and Fibrinolysis

Volumn 16, Issue 3, 2005, Pages 205-208

  Ivaskevicius, Vytautas ^a   Jusciute, Egle ^b   Steffens, Michael ^b   Geisen, Christof ^a   Hanfland, Peter ^b   Wienker, Thomas F ^b   Seifried, Erhard ^a   Oldenburg, Johannes ^a,b,c  

^a Institute of Transfusion Medicine and Immune Hematology   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c Inst Transfus Med I   (Germany)

Author keywords

Denaturing high performance liquid chromatography; Fibrinogen; Founder effect; Mutations; Screening

Indexed keywords

ALANINE; FIBRINOGEN; GLYCINE;

ALLELE; ARTICLE; BLOOD DONOR; CAUCASIAN; FEMALE; FGA GENE; FGB GENE; FGG GENE; FIBRINOGEN METABOLISM; GENE; GENE FREQUENCY; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPOFIBRINOGENEMIA; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; POPULATION RISK; PRIORITY JOURNAL; PROTEIN VARIANT; AMINO ACID SUBSTITUTION; BLOOD CLOTTING TEST; COHORT ANALYSIS; DOMINANT GENE; GENETIC SCREENING; GENETIC VARIABILITY; GENETICS; HETEROZYGOTE; METHODOLOGY;

AMINO ACID SUBSTITUTION; BLOOD COAGULATION TESTS; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FIBRINOGEN; GENES, DOMINANT; GENETIC SCREENING; HETEROZYGOTE; HUMANS; MALE; MUTATION, MISSENSE; POLYMORPHISM, GENETIC; VARIATION (GENETICS);

EID: 17444393182     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mbc.0000164430.98169.c6     Document Type: Article

References (9)

1. Chung DW, Harris JE, Davie EW. Nucleotide sequences of the three genes coding for human fibrinogen. Adv Exp Med Biol 1990; 281: 39-48.
2. Hanss M, Biot F. A database for human fibrinogen variants. Ann NY Acad Sci 2001; 936:89-90.
3. Jones AC, Austin J, Hansen N, Hoogendoorn B, Oefner PJ, Cheadle JP, et al. Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis. Clin Chem 1999; 45:1133-1140.
4. Brennan SO, Fellowes AP, Faed JM, George PM. Hypofibrinogenemia in an individual with 2 coding (gamma82 A → G and Bbeta235 P → L) and 2 noncoding mutations. Blood 2000; 95:1709-1713.
5. Wyatt J, Brennan SO, May S, George PM. Hypofibrinogenaemia with compound heterozygosity for two gamma chain mutations - gamma 82 Ala → Gly and an intron two GT → AT splice site mutation. Thromb Haemost 2000; 84:449-452.
6. van't Hooft FM, von Bahr SJ, Silveira A, Iliadou A, Eriksson P, Hamsten A. Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration. Arterioscler Thromb Vasc Biol 1999; 19:3063-3070.
7. Behague I, Poirier O, Nicaud V, Evans A, Arveiler D, Luc G, et al. Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde. Circulation 1996; 93:440-449.
8. Fellowes AP, Brennan SO, George PM. Identification and characterization of five new fibrinogen gene polymorphisms. Ann NY Acad Sci 2001; 936:536-541.
9. Maghzal GJ, Brennan SO, Fellowes AP, Spearing R, George PM. Familial hypofibrinogenaemia associated with heterozygous substitution of a conserved arginine residue; Bbeta255 Arg → His (Fibrinogen Merivale). Biochim Biophys Acta 2003; 1645:146-151.